Ian Greer

Q: What Schools Are Affiliated With Ian Greer

Ian Greer is affiliated with the following schools: University of Liverpool, University of Hull, University of Medicine, Taunggyi, University of Edinburgh, University of Glasgow, University of Manchester

Ian Greer 's AcademicInfluence.com Rankings

Ian Greer

Philosophy

#4337

World Rank

#6816

Historical Rank

Logic

#2493

World Rank

#3495

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Ian Greer 's Degrees

Doctorate Medicine University of Medicine, Taunggyi

Why Is Ian Greer Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Professor Sir Ian Andrew Greer is a medical doctor who is the President and Vice Chancellor of Queen's University Belfast and formerly Vice-President of the University of Manchester and Dean of the Faculty of Medical and Human Sciences. He was Regius Professor of Obstetrics and Gynaecology at the University of Glasgow 2001−2007, Dean at Hull York Medical School 2007–2010, then Pro-Vice-Chancellor of the Faculty of Health and Life Sciences at the University of Liverpool 2010−2015.

(See a Problem?)

Ian Greer 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

International consensus report on the investigation and management of primary immune thrombocytopenia. (2010) (1778)
Venous thromboembolism (VTE) in Europe (2007) (1348)
VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) (1136)
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women (1994) (889)
Thrombophilia in pregnancy: a systematic review (2006) (798)
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (2008) (796)
Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? (2002) (765)
Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy (2003) (755)
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. (2005) (717)
Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. (2003) (645)
Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. (2002) (632)
Thrombosis in pregnancy: maternal and fetal issues (1999) (551)
Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. (1999) (512)
Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004) (512)
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. (2006) (473)
Guidelines on the investigation and management of antiphospholipid syndrome (2012) (452)
Risk of and Prophylaxis for Venous Thromboembolism in Hospital Patients (1998) (434)
Risk Factors for Pregnancy Associated Venous Thromboembolism (1997) (422)
Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. (1996) (398)
Activated Protein C Sensitivity, Protein C, Protein S and Coagulation in Normal Pregnancy (1998) (384)
Manifestations of chronic disease during pregnancy. (2005) (378)
Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. (2002) (368)
Immunolocalization of Proinflammatory Cytokines in Myometrium, Cervix, and Fetal Membranes During Human Parturition at Term1 (2002) (346)
Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. (1996) (327)
Lipoprotein Subfraction Concentrations in Preeclampsia: Pathogenic Parallels to Atherosclerosis (1997) (326)
Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia (2004) (286)
Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital (2005) (285)
Increased concentrations of dytokines interleukin and interleukin‐1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction? (1994) (283)
Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? (2004) (283)
Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. (2007) (264)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. (2018) (257)
Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. (1996) (257)
SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. (2010) (251)
Guidance for the treatment and prevention of obstetric-associated venous thromboembolism (2016) (249)
The Association of Factor V Leiden and Prothrombin Gene Mutation and Placenta-Mediated Pregnancy Complications: A Systematic Review and Meta-analysis of Prospective Cohort Studies (2010) (239)
Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review (2005) (227)
Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. (1997) (219)
Term labor is associated with a core inflammatory response in human fetal membranes, myometrium, and cervix. (2009) (214)
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial (2014) (212)
An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy (1997) (212)
Venous Thromboembolic Disease in Obstetrics and Gynaecology: The Scottish Experience (1996) (196)
Classic and Novel Risk Factor Parameters in Women With a History of Preeclampsia (2003) (190)
Prevention and treatment of venous thromboembolism--International Consensus Statement. (2013) (188)
Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. (2002) (182)
Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. (1997) (182)
Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters (2001) (178)
Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre‐eclampsia (1997) (173)
Paradoxical Elevation in Adiponectin Concentrations in Women With Preeclampsia (2003) (166)
Evidence-Based Clinical Practice Guidelines ed: American College of Chest Physicians Therapy and Prevention of Thrombosis, 9th Therapy, and Pregnancy : Antithrombotic VTE, Thrombophilia, Antithrombotic (2012) (163)
Thrombophilia and Pregnancy Complications (2015) (155)
Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. (1997) (153)
Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. (1995) (153)
Microvascular dysfunction: a link between pre‐eclampsia and maternal coronary heart disease (2003) (148)
Venous Thromboembolism , Thrombophilia , Antithrombotic Therapy , and Pregnancy (2008) (148)
Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre‐eclampsia (1996) (147)
Screening for thrombophilia in high‐risk situations: a meta‐analysis and cost‐effectiveness analysis (2005) (143)
The potential role of heparin in assisted conception. (2008) (141)
The cell adhesion molecule, VCAM‐1, is selectively elevated in serum in pre‐eclampsia: does this indicate the mechanism of leucocyte activation? (1994) (139)
Centile charts for birthweight for gestational age for Scottish singleton births (2008) (138)
Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial (1997) (136)
Patients With Cancer (2013) (132)
Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology (1998) (131)
Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. (2006) (130)
Thrombophilia: implications for pregnancy outcome. (2003) (130)
Prevention and Treatment of Venous Thromboembolism (2013) (125)
Neutrophil activation in pregnancy‐induced hypertension (1989) (119)
Leptin levels in pregnancy, marker for fat accumulation and mobilization? (1998) (117)
Inherited thrombophilia and pregnancy complications revisited. (2008) (111)
Antenatal Waist Circumference and Hypertension Risk (2001) (108)
Increased Nitrotyrosine in the Diabetic Placenta: Evidence for oxidative stress (1998) (108)
Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. (1996) (104)
Leukocyte Density and Proinflammatory Mediator Expression in Regional Human Fetal Membranes and Decidua Before and During Labot at Term (2006) (104)
Inverse Association Between Birth Weight and C-Reactive Protein Concentrations in the MIDSPAN Family Study (2004) (103)
Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy (2000) (103)
The challenge of thrombophilia in maternal-fetal medicine. (2000) (102)
Lipid and lipoprotein concentrations in pregnancies complicated by intrauterine growth restriction. (1999) (101)
The vascular endothelium in normal pregnancy and pre-eclampsia. (1996) (99)
Obesity and reproduction (2006) (99)
Changes in the expression of nitric oxide synthase in the human uterine cervix during pregnancy and parturition. (2000) (95)
Prothrombin 20210 G→A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy (2000) (92)
The neutrophil and preeclampsia. (1998) (91)
The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes (2007) (90)
Low molecular weight heparin in pregnancy: current issues (2005) (89)
Prevention of venous thromboembolism in pregnancy. (2003) (87)
Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. (2004) (85)
Nitric oxide synthase activity and localization do not change in uterus and placenta during human parturition. (1997) (84)
Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, pre-eclamptic and intrauterine growth-restricted pregnancies. (1997) (84)
Thrombosis in pregnancy: updates in diagnosis and management. (2012) (83)
Factors Critical to Iontophoretic Assessment of Vascular Reactivity: Implications for Clinical Studies of Endothelial Dysfunction (2002) (83)
Endothelin, elastase, and endothelial dysfunction in pre-eclampsia (1991) (82)
Elimination of Electrically Induced Iontophoretic Artefacts: Implications for Non-Invasive Assessment of Peripheral Microvascular Function (2002) (80)
Pre-eclampsia: a multifaceted vascular disorder of pregnancy. (1994) (80)
Platelet function after intramuscular diclofenac (1990) (78)
1 Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology (1997) (77)
Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy (1998) (76)
Contribution of smoking during pregnancy to inequalities in stillbirth and infant death in Scotland 1994-2003: retrospective population based study using hospital maternity records (2009) (75)
Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile. (2011) (73)
A Longitudinal Study of the Relationships between Haemostatic, Lipid, and Oestradiol Changes during Normal Human Pregnancy (1999) (73)
Haemostatic Effects of Ketorolac with and without Concomitant Heparin in Normal Volunteers (1988) (73)
A population-based study of venous thrombosis in pregnancy in Scotland 1980-2005. (2013) (71)
Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series. (2003) (70)
Differential Localization of Superoxide Dismutase Isoforms in Placental Villous Tissue of Normotensive, Pre-eclamptic, and Intrauterine Growth-restricted Pregnancies (1997) (70)
Social inequalities in preterm birth in Scotland 1980–2003: findings from an area‐based measure of deprivation (2007) (69)
The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: Significance of Pregnancy Associated Activated Protein C Resistance (2001) (69)
The role of inherited thrombophilia in venous thromboembolism associated with pregnancy (1999) (68)
Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium. (2016) (67)
Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy‐induced hypertension (1991) (63)
Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow (2001) (62)
Nitric oxide in parturition (2000) (62)
The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. (2001) (61)
The "PRIM" study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. (2004) (61)
Effects of cGMP and the nitric oxide donors glyceryl trinitrate and sodium nitroprusside on contractions in vitro of isolated myometrial tissue from pregnant women. (1997) (61)
Prevention and management of venous thromboembolism in pregnancy. (2003) (60)
Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women (2002) (60)
Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy (1998) (59)
Longitudinal Assessment of Erythrocyte Fatty Acid Composition Throughout Pregnancy and Post Partum (2007) (58)
Elaboration of stem villous vessels in growth restricted pregnancies with abnormal umbilical artery Doppler waveforms (1995) (58)
Chemokine Scavenger D6 Is Expressed by Trophoblasts and Aids the Survival of Mouse Embryos Transferred into Allogeneic Recipients (2010) (58)
Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium. (2006) (57)
Inherited thrombophilia and venous thromboembolism. (2003) (57)
Use of antithrombotic agents during pregnancy. (1993) (57)
The deep venous system in the puerperium: an ultrasound study (1997) (57)
Effects of Ketorolac Tromethamine on Hemostasis (1990) (56)
Expression of cell adhesion molecules in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth retardation. (1995) (56)
Doppler umbilical artery flow velocity waveforms in diabetic pregnancy (1992) (56)
Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series (2002) (55)
Lipoprotein (a) levels in normal pregnancy and in pregnancy complicated with pre-eclampsia. (2000) (55)
Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. (2000) (55)
Effects of algorithm for diagnosis of active labour: cluster randomised trial (2008) (54)
Pulmonary thrombo-embolism in pregnancy: diagnosis and management (2015) (54)
Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics. (2001) (54)
Recombinant human relaxin as a cervical ripening agent (1997) (54)
Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restriction: relevance of adiposity (2004) (52)
Human Placental Peroxisome Proliferator-Activated Receptor δ and γ Expression in Healthy Pregnancy and in Preeclampsia and Intrauterine Growth Restriction (2005) (52)
Mechanical stretch increases proto‐oncogene expression and phosphoinositide turnover in vascular smooth muscle cells (1994) (52)
Insulin-sensitising agents in polycystic-ovary syndrome (1998) (49)
CLINICAL PRACTICE. Pregnancy Complicated by Venous Thrombosis. (2015) (49)
Metabolic, inflammatory and haemostatic effects of a low‐dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? (2003) (47)
Non-haemorrhagic obstetric shock. (2000) (47)
Essential fatty acids in relation to pregnancy complications and fetal development (1998) (47)
Preeclampsia Is Associated With Compromised Maternal Synthesis of Long-Chain Polyunsaturated Fatty Acids, Leading to Offspring Deficiency (2012) (46)
The effect of introduction of umbilical Doppler recordings to obstetric practice (1993) (46)
Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology. (1997) (46)
Thromboprophylaxis following Caesarean Section (2001) (45)
Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine? (2014) (45)
The effects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers. (1984) (44)
A comparison of isosorbide mononitrate, misoprostol and combination therapy for first trimester pre‐operative cervical ripening: a randomised controlled trial (2001) (43)
Apparent interaction between warfarin and levonorgestrel used for emergency contraception (2000) (43)
Pregnancy Complicated by Venous Thrombosis (2015) (43)
ABC of obesity. Obesity and reproduction. (2006) (43)
Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. (2006) (42)
Management of venous thromboembolism in pregnancy. (2001) (42)
Superficial Vein Thrombosis: Incidence in Association with Pregnancy and Prevalence of Thrombophilic Defects (1998) (41)
Inherited Thrombophilia and Pregnancy Complications Revisited (2009) (41)
Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro. (1986) (38)
Anti-Activated Factor X Profiles in Pregnant Women Receiving Antenatal Thromboprophylaxis with Enoxaparin (1999) (38)
Expression of superoxide dismutase and xanthine oxidase in myometrium, fetal membranes and placenta during normal human pregnancy and parturition. (1997) (36)
Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. (2005) (36)
Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight (1999) (35)
Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared. (1983) (35)
Puerperal thromboprophylaxis: comparison of the anti‐Xa activity of enoxaparin and unfractionated heparin (1998) (35)
Venous thromboembolism and anticoagulant therapy in pregnancy. (2005) (35)
The Special Case of Venous Thromboembolism in Pregnancy (1998) (35)
Cervical ripening after nitric oxide. (1998) (35)
Circulating leptin concentrations and ovarian function in polycystic ovary syndrome. (2001) (35)
Technical note: compression stockings and posture: a comparative study of their effects on the proximal deep veins of the leg at rest. (1995) (34)
Increased Neutrophil Activation in Diabetic Pregnancy and in Nonpregnant Diabetic Women (1989) (34)
Myometrial constitutive nitric oxide synthase expression is increased during human pregnancy. (1999) (34)
Vaginal Administration of PGE2 for Induction of Labor Stimulates Endogenous PGF2a Production (1990) (33)
Anaesthetic considerations in a parturient with critical coronary artery disease and a drug-eluting stent presenting for caesarean section. (2005) (32)
Interaction of the protein C/protein S anticoagulant system, the endothelium and pregnancy. (1999) (31)
Is screening for thrombophilia cost-effective? (2007) (31)
Plasma protein Z deficiency is common in women with antiphospholipid antibodies (2003) (31)
Increased platelet reactivity in pregnancyinduced hypertension and uncomplicated diabetic pregnancy: an indication for antiplatelet therapy? (1988) (31)
Fetal corticotrophin‐releasing hormone mRNA, but not phosphatidylserine‐exposing microparticles, in maternal plasma are associated with factor VII activity in pre‐eclampsia (2008) (29)
The effect of pH on release of PGE2 from vaginal and endocervical preparations for induction of labour: an in‐vitro study (1992) (29)
Enhancement of endothelial function by pregnancy: inadequate response in women with type 1 diabetes. (2003) (29)
Anticoagulants in Pregnancy (2006) (28)
Familial thrombophilia and activated protein C resistance: thrombotic risk in pregnancy? (1994) (28)
Pre-eclampsia matters (2005) (28)
HELLP syndrome: pathologic entity or technical inadequacy? (1985) (28)
The parturient with coronary heart disease. (2008) (27)
Exploring the role of low-molecular-weight heparins in pregnancy. (2002) (27)
Vascular dysfunction and alteration of novel and classic cardiovascular risk factors in mothers of growth restricted offspring. (2009) (27)
The acute management of venous thromboembolism in pregnancy (2001) (27)
Procoagulant Microparticles: New Insights and Opportunities in Pregnancy Loss? (2001) (27)
Obesity in pregnancy: risks and management (2009) (27)
Immunoreactive prostacyclin and thromboxane metabolites in normal pregnancy and the puerperium (1985) (27)
A systematic review on the use of new anticoagulants in pregnancy (2013) (27)
ASPIRIN WITH AN ADRENERGIC OR A CALCIUM-CHANNEL-BLOCKING AGENT AS NEW COMBINATION THERAPY FOR ARTERIAL THROMBOSIS (1985) (26)
Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985-1990. (1994) (26)
Anaphalactoid reaction to ranitidine in labour (1990) (25)
Neutrophil activation in small for gestational age pregnancies (1991) (24)
Erratum: Inherited thrombophilia and pregnancy complications revisited (Obstetrics & Gynecology (2008) 112 (320-324)) (2008) (24)
Thrombophilia and adverse pregnancy outcome (2004) (24)
The impact of guidelines on mild hypertension in pregnancy: time series analysis (2004) (24)
Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome (2016) (22)
Gestational related changes in the deep venous system of the lower limb on light reflection rheography in pregnancy and the puerperium. (2007) (22)
Placental proopiomelanocortin gene expression, adrenocorticotropin tissue concentrations, and immunostaining increase throughout gestation and are unaffected by prostaglandins, antiprogestins, or labor. (1996) (22)
Pharmacological modulation of cervical compliance in the first and second trimesters of pregnancy. (1991) (21)
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) (2011) (21)
HELLP syndrome: mechanisms and management. (1999) (20)
Use of enoxaparin in a pregnant woman with a mechanical heart valve prosthesis (2001) (20)
Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasis. (1998) (19)
Thromboembolism in pregnancy (2005) (19)
Endothelial function is preserved in pregnant women with well‐controlled type 1 diabetes (2002) (19)
A Comparative Study of the Effects of Adrenoceptor Antagonists on Platelet Aggregation and Thromboxane Generation (1985) (19)
THE CELL ADHESION MOLECULE, VCAM-1, IS SELECTIVELY ELEVATED IN SERUM IN PRE-ECLAMPSIA : DOES THIS INDICATE THE MECHANISM OF LEUCOCYTE ACTIVATION ? AUT HOR'S REPLY (1995) (19)
MEASUREMENT OF PROSTACYCLIN METABOLITES (1983) (18)
The effect of pH on release of PGE2 from vaginal and endocervical preparations for induction of labor: An in vitro study (1993) (18)
5 Prostaglandins and the cervix (1992) (18)
Coagulation and Placenta-Mediated Complications (2014) (17)
Thrombocytopenia, antithrombin deficiency and extensive thromboembolism in pregnancy: treatment with low-molecular-weight heparin. (1995) (17)
Inferior Vena Cava Filters (2013) (17)
Low-molecular-weight heparin for the prevention and treatment of venous thromboembolism in pregnancy (2004) (17)
IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour – clinical trial with analyses of efficacy, cost effectiveness and acceptability (2006) (17)
Intravenous Prostacyclin in the Management of Pregnancies Complicated by Severe Hypertension (1985) (17)
Gemeprost-induced cervical ripening: histological and biophysical effects. (1992) (17)
Dexamethasone inhibits basal and stimulated prostaglandin E2 output from human placental cells by inhibition of prostaglandin H synthase. (1992) (16)
Changes in prostaglandin synthesis and metabolism associated with labour, and the influence of dexamethasone, RU 486 and progesterone. (1995) (16)
Antithrombotic treatment for recurrent pregnancy loss? (2011) (16)
The development and testing of an algorithm for diagnosis of active labour in primiparous women. (2008) (16)
The role of factor V Leiden in maternal health and the outcome of pregnancy. (2005) (16)
Endothelial cell microparticles and antiphospholipid syndrome: pathologic explanations and diagnostic opportunities (2004) (16)
Antithrombotic therapy for recurrent miscarriage? (2010) (16)
Gynecology and Obstetrics (2013) (15)
Ambulatory blood pressure in pregnancy: measurements and machines (1993) (15)
Management of inherited thrombophilia in pregnancy (2016) (15)
Leukocytes infiltrate the myometrium during human parturition (1999) (15)
Prevention and treatment of arterial thrombosis in pregnancy. (2003) (15)
Effect of maternal ketorolac administration of platelet function in the newborn. (1988) (14)
A mutation in the prothrombin gene contributing to venous thrombosis during pregnancy (1998) (14)
Prostaglandins and the cervix. (1992) (14)
Recommendations for prophylaxis of pregnancy-related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines. (2013) (14)
Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists. (1985) (14)
Maternal medicine : medical problems in pregnancy (2007) (14)
Thrombocytopenia and leucopenia precipitated by pregnancy in a woman with myasthenia gravis (2000) (14)
Relationship between myometrial resistance artery behavior and circulating lipid composition. (1999) (14)
Outcomes of pregnancy complicated by thyroid disease (2005) (14)
Thrombophilia and venous thromboembolism after total hip or knee replacement surgery: a systematic review (2005) (14)
Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists. (1985) (14)
Effect of supplementation with folic acid throughout pregnancy on plasma homocysteine concentration. (2004) (13)
Risk factors for venous thromboembolism in pregnancy. (1999) (13)
United Kingdom recommendations for obstetric venous thromboembolism prophylaxis: Evidence and rationale. (2019) (13)
The effect of type 1 diabetes mellitus on vascular responses to endothelin-1 in pregnant women. (2001) (12)
Plasma prostaglandin metabolite concentrations in normal and dysfunctional labour (1993) (12)
Topical Pramoxine and Hydrocortisone Foam versus Placebo in Relief of Post Partum Episiotomy Symptoms and Wound Healing (1984) (12)
Preterm labour : managing risk in clinical practice (2005) (12)
PLATELETS IN ASTHMA (1984) (12)
Platelet Activation in Allergic Asthma (1985) (12)
Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles. (2002) (12)
‘To test or not to test’, the arguments for and against thrombophilia testing in obstetrics (2017) (11)
(8th Edition) Evidence-Based Clinical Practice Guidelines American College of Chest Physicians Antithrombotic Therapy, and Pregnancy: Venous Thromboembolism, Thrombophilia, (2008) (11)
Reduced Prostacyclin Production by Umbilical Arteries from Pregnancy Complicated by Severe Pregnancy Induced Hypertension (1987) (11)
Circulating Cell Adhesion Molecule Concentrations in Diabetic Women During Pregnancy (1997) (11)
Effect of Stanozolol on Factors VIII and IX and Serum Aminotransferases in Haemophilia (1985) (11)
Treatment for Patients With Cancer (2013) (10)
Recommendations for prophylaxis of pregnancy‐related venous thromboembolism in carriers of inherited thrombophilia. Comment on the 2012 ACCP guidelines: a rebuttal (2013) (10)
Duplex ultrasound screening for deep venous thrombosis in the puerperium (1995) (10)
Lipids and the pathogenesis of pre-eclampsia (1999) (10)
POINT INVESTIGATORS. KETOROLAC, DICLOFENAC, AND KETOPROFEN ARE EQUALLY SAFE FOR PAIN RELIEF AFTER MAJOR SURGERY (2002) (9)
Hypertensive disorders of pregnancy: preventative-, immediate- and long-term management (2006) (9)
Treatment of Endothelial Cells With Serum from Women with Preeclampsia: Effect on Neutrophil Adhesion (1997) (9)
THERAPEUTIC PROGRESS–REVIEW XXVIII: PLATELET FUNCTION AND CALCIUM CHANNEL BLOCKING AGENTS (1987) (9)
Hypercoagulable states and pregnancy. (2002) (9)
Working alongside a midwife‐led care unit: what do obstetricians think? (1995) (9)
The influence of amniotic fluid on prostaglandin synthesis and metabolism in human fetal membranes (1998) (9)
Anticoagulation with Tinzaparin for women with mechanical valves in pregnancy: a retrospective case series. (2013) (9)
A PROSPECTIVE LONGITUDINAL STUDY OF IMMUNOREACTIVE PROSTACYCLIN AND THROMBOXANE METABOLITES IN NORMAL AND HYPERTENSIVE PREGNANCY (1985) (9)
Thromboembolic problems in pregnancy (1989) (9)
Thrombosis and pregnancy (2005) (9)
Second Line Therapy with Nifedipine in Severe Pregnancy Induced Hypertension (1989) (9)
Umbilical artery Doppler flow velocity waveforms and maternal prostaglandin E2 and F2 alpha metabolite concentrations during cervical ripening with prostaglandin E2. (1990) (8)
Prostaglandins: A Key Factor in Human Labor (1990) (8)
Textbook of periconceptional medicine (2008) (8)
The impact of national clinical guidelines on obstetricians in Scotland. (2001) (8)
Prostaglandins and the biological control of cervical function. (1990) (8)
Platelet function in pregnancy induced hypertension following treatment with labetalol and low dose aspirin. (1987) (8)
Diagnosis and Anticoagulant Treatment * (2013) (7)
Role of prostaglandin in the management of prelabour rupture of the membranes at term (1992) (7)
Periprocedural Management of Antithrombotic Therapy and Use of Bridging Anticoagulation (2008) (7)
Venous thrombosis prevention – more than just guidelines (2010) (7)
Pre-induction cervical ripening with extra-amniotic and vaginal prostaglandin E2 (1989) (7)
Thromboembolic events in pregnancy: pharmacological prophylaxis and treatment (2007) (7)
Plasma prostaglandin metabolite concentrations in normal and dysfunctional labor (1994) (7)
Protein Z in pregnancy: exaggerated rise in obese women (2005) (7)
LMWH in IVF - Biomarkers and benefits. (2017) (6)
A relationship between myometrial resistance artery behaviour and circulating lipid composition (1998) (6)
Endothelial stimulation by DDAVP in von Willebrand's disease and haemophilia. (1986) (6)
Corticotrophin‐releasing factor immunostaining is present in placenta and fetal membranes from the first trimester onwards and is not affected by labour or administration of mifepristone (1994) (6)
Lack of association between maternal phosphoglucomutase‐1 phenotype and fetal macrosomia in diabetic pregnancy (1994) (6)
Nitric oxide donors induce ripening of the human uterine cervix (1997) (6)
Medical patients. (2013) (6)
Women's Vascular Health (2006) (5)
The cell adhesion molecule, VCAM-1 is selectively elevated in serum in preeclampsia: Does this indicate the mechanism of neutrophil activation? (1993) (5)
Pregnancy after bariatric surgery: no problem? (2009) (5)
The G-to-T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia (2003) (5)
Maternal plasma bicycling PGE2 levels following vaginal administration of prostaglandin E2 pessaries in full term pregnancies. (1987) (5)
Autocoid synthesis and action in abnormal placental flows reviewed: Causative vs. compensatory roles (1998) (5)
Treatment of Endothelial Cells With Serum from Women with Preeclampsia: Effect on Neutrophil Adhesion (1997) (5)
The influence of maternal Lewis, Secretor and ABO(H) blood groups on fetal growth restriction (2011) (4)
Endothelin stimulates ACTH secretion in the ovine fetus. (1995) (4)
Statins as novel therapies for osteoporosis? (2002) (4)
Practical strategies for hormone replacement therapy and risk of venous thromboembolism (1998) (4)
ANTIHYPERTENSIVE THERAPY IN PREGNANCY (1983) (4)
Umbilical artery perfusion: A method to measure prostacyclin production in vitro (1986) (4)
Moles and sandwiches (1994) (4)
Cardiovascular Health and Maternal Placental Syndromes (2011) (4)
Haematological Problems in Pregnancy (2012) (4)
Commentary: Obstetrician's perspective—therapeutic trial and error? (2004) (4)
Metabolic, Inflammatory, and Hemostatic Effects of a Low-Dose Continuous Combined HRT in Women With Type 2 Diabetes: Potentially Safer With Respect to Vascular Risk (2004) (4)
The low dose aspirin controversy solved at last? (1985) (4)
Diagnosis prevention and treatment of gestational venous thromboembolism (2002) (3)
Changing childbirth, I and II (1994) (3)
LOCOMOTION OF HUMAN NEUTROPHILS IN RESPONSE TO PLASMA AND SERUM OF WOMEN WITH PREECLAMPSIA (1996) (3)
Insulin sensitivity in pre‐eclampsia (1999) (3)
Distribution of Calcium/Creatinine Ratio in Pregnancy Induced Hypertension (1991) (3)
Hormone Replacement Therapy is Not a Risk for Venous Thrombosis (1994) (3)
Synergistic inhibitory effects of adrenoceptor antagonists and prostacyclin, and umbilical artery-derived prostacyclin-like activity on platelet aggregation. (1990) (3)
Effects of ketorolac and dextran‐70 alone and in combination on haemostasis (1998) (3)
Hormone replacement therapy and venous thromboembolism. (1999) (3)
Thromboxane A2 and prostacyclin levels in molar pregnancy (1985) (3)
Alternative mechanisms for the hypotensive effects of adrenergic blockade. (1983) (3)
Screening for Antiphospholipid Antibodies in Women With Pregnancy Complications: Response (2012) (3)
Cost-Effectiveness of Prevention and Treatment of VTE (2013) (3)
Low-molecular-weight heparin for pregnancy complications (2016) (3)
Mechanisms involved in the stimulatory effect of amniotic fluid on prostaglandin production by human fetal membranes. (1998) (3)
BARIATRIC SURGERY IN PREGNANCY: BENEFITS, RISKS AND OBSTETRIC MANAGEMENT (2011) (3)
Phylogeny of Wilms tumor? (2016) (3)
OBESITY IN PREGNANCY (2004) (2)
The Transfer of Prostaglandin E2 Across Ovine Fetal Membranes In Vivo (1996) (2)
Problem-based obstetrics and gynaecology (2003) (2)
ANXA5: A Key to Unlock the Mystery of the Spectrum of Placental-Mediated Pregnancy Complications? (2016) (2)
General, Vascular, Bariatric, and Plastic Surgical Patients (2013) (2)
Prostacyclin in normal and hypertensive pregnancy. (1985) (2)
Insulin‐mediated vasorelaxation in pregnancy (2001) (2)
Thromboembolism in gynaecological surgery (1998) (2)
Nitrotyrosine residues in the placenta in preeclampsia and IUGR: Evidence for the formation and action of peroxynitrite and vascular damage. (1996) (2)
Obstetrician's perspective—therapeutic trial and error? (2004) (2)
The "PRIM" study - A randomised comparison of prostaglandin with isosorbide mononitrate for pre-induction cervical ripening at term. (2004) (2)
Micro-Albuminuria in Random Daytime Specimens in Pregnancy Induced Hypertension (1991) (2)
Screening for thrombophilia: an economic assessment (2003) (2)
Combined Modalities in Surgical Patients (2013) (2)
Thromboembolic Disease in Pregnancy (2010) (2)
The Cytokine Interleukin-6 Increases Expression of the Cell Adhesion Molecules E-Selectin and VCAM-1 on Endothelial Cells in Vitro: A Role in Preeclampsia? (1997) (2)
Superficial vein thrombosis: incidence in association with pregnancy and prevalence of thrombophilic abnormalities (1997) (2)
Thrombophilia and pregnancy outcome (2005) (2)
Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305] (2016) (2)
Kleihauer testing. Many cases of sensitisation may be avoidable. (1994) (2)
Surgical thrombectomy. (2013) (2)
Mosby's color atlas and text of obstetrics and gynecology (2001) (2)
Obesity: impact on obstetric practice and outcome (2009) (2)
Points: Orange periods (1984) (2)
Immunolocalization of inducible nitric oxide synthase in human amnion. (1999) (2)
The Obstetric Hematology Manual: Acute management of suspected thromboembolic disease in pregnancy (2010) (2)
Abstracts presented at a joint meeting of the Blair Bell Research Society and the Developmental Origins of Health and Disease Society at Southampton University 30th September–1st October 2004 (2005) (1)
Antithrombotic Therapy , and Pregnancy : Venous Thromboembolism , Thrombophilia (2008) (1)
Leptin and body fat in pre-eclampsia and intrauterine growth restriction: a protective role for leanness? (2003) (1)
Reply to Heparin's ‘potential to improve pregnancy rates and outcomes’ is not evidence-based (2010) (1)
and efficacy venous thromboembolism in pregnancy: a systematic review of safety Low-molecular-weight heparins for thromboprophylaxis and treatment of (2013) (1)
Management of venous thrombosis in pregnancy (2008) (1)
Key Questions to be Answered (2013) (1)
Obesity in young women during pregnancy. (2010) (1)
Fetal growth, gestation length and phosphoglucomutase-1 phenotype. (1993) (1)
Haematuria in patients with haemostatic defects. (1985) (1)
A longitudinal study of the relationship between lipid, haemostatic and hormonal changes during normal human pregnancy (1998) (1)
Hematology measurements in pregnancy (2005) (1)
Orthopedic Surgery and Trauma (2013) (1)
Pulmonary thrombo-embolism in pregnancy: diagnosis and (2015) (1)
The hyperlipidaemia of normal pregnancy (1995) (1)
The Problem and the Need for Prevention (2013) (1)
The Menopause in Practice (2002) (1)
Thrombolytic Therapy (2013) (1)
women with recurrent miscarriage controlled trial of low-molecular-weight heparin and low-dose aspirin in SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized (2014) (1)
Critical Care Medical Patients (2013) (1)
Placental corticotrophin‐releasing hormone RNA and microparticles in maternal plasma are not measures of placental shedding of debris: reply to a rebuttal (2008) (1)
Antithrombotic therapy for pregnancy complications: let's not throw the baby out with the bath water (2014) (1)
Evidence over hope for pregnancy complications. (2012) (1)
Complications of erythema infectiosum in pregnancy (1988) (1)
The Effect of Endralazine and Hydralazine on Platelet Thromboxane Production in Vitro (1987) (1)
Plasma apolipoprotein A1 and birthweight (1998) (1)
Effects of Algorithm for Diagnosis of Active Labor: Cluster Randomized Trial (2010) (1)
Advances in Low Molecular Weight Heparin Use in Pregnancy (2005) (1)
Transforming growth factor ?-3 expression in placentae from normal pregnancies and pregnacies complicated by intrauterine growth retardation with abnormal umbilical artery waveforms (1995) (1)
Scottish group is developing guideline for managing pregnant women with epilepsy (2000) (0)
O15 The perioperative injectable non-steroidal trial (POINT) and perioperative bleeding (1998) (0)
The effect of hormone replacement therapy on the expression of monocyte tissue factor (2004) (0)
Prevention of Postthrombotic Syndrome (2013) (0)
Management of venousthromboembolism duringpregnancy (2005) (0)
Maternal Critical Care: Thromboembolism (2013) (0)
Effects of metformin on obese women with Polycystic Ovary Syndrome (PCOS) (1998) (0)
The patient with tubal disease A Strandell (2008) (0)
Possible risks of hormone replacement therapy (HRT): venous thromboembolism (VTE) (2005) (0)
Patient at High Risk of Venous Thrombosis (2016) (0)
Desamino-8-d-arginine vasopressin and prostacyclin production in von Willebrands disease (1986) (0)
CORRESPONDENCE Thromboxane A2 and prostacyclin levels in molar (1985) (0)
Achieving pregnancy in the anovulatory woman RS Legro and A Dokras (2008) (0)
Thrombocytopenia in pregnancy (2005) (0)
Response: Adiponectin Concentrations in Preeclampsia (2004) (0)
Constitutive nitric oxide synthase expression is increased in human myometrium during pregnancy and decreases before term (1998) (0)
Thromboprophylaxis in Pregnancy, Orthopaedic Surgery Patients and in Long-Term Strategies (1998) (0)
Microalbuminuria in Pregnancy Induced Hypertension (1991) (0)
Serum from women with pre-eclampsia stimulates cell adhesion molecule mrna expression on endothelial cells in vitro (1995) (0)
Comprar Maternal Medicine | Ian A. Greer | 0443101299 | Churchill Livingstone (2007) (0)
Bleeding disorders in pregnancy (2005) (0)
' s response to reviews Title : Incident venous thrombotic events in the Prospective Study of Pravastatin in the Elderly at Risk ( PROSPER ) (2010) (0)
14.7 Thrombosis in pregnancy (2010) (0)
Recipients Embryos Transferred into Allogeneic Trophoblasts and Aids the Survival of Mouse Chemokine Scavenger D 6 Is Expressed by and (2010) (0)
Review Obesity: impact on obstet ric practice and outcome (2009) (0)
Pulmonary embolism and pregnancy (2004) (0)
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efﬁcacy (2005) (0)
Management of thrombotic disorders (2005) (0)
Hereditary red cell disorders (2005) (0)
The use of LMWH in pregnancies at risk: new evidence or perception? (2005) (0)
Recurrent miscarriage: is conservative management the best we can offer? (2015) (0)
Blood group serology and blood products (2005) (0)
Fibrinolytic markers in pregnancy: relationship to pertubations in lipoprotein levels (1995) (0)
Venous Thrombosis in Women: Pregnancy, the Contraceptive Pill and Hormone Replacement Therapy (2003) (0)
Maternal anemia and hemato-oncology in pregnancy (2005) (0)
Low molecular weight heparin: the answer to adverse outcomes in obstetrics? (2012) (0)
1B.1 Risk factors and diagnosis of VTE in pregancy (2007) (0)
Other Uses of LMWHs – Miscellaneous (1998) (0)
Prevention of Venous Thromboembolism and Pregnancy Complications using Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review of Safety and Thromboprophylactic Efficacy. (2004) (0)
Hormonal Therapy in Women (2006) (0)
Haematuria in Patients With Haemostatic Defects (1985) (0)
IMMUNOLOCALIZATION OF INDUCIBLE NITRIC OXIDE SYN THASE IN HUMAN AMNION. AUTHORS' REPLY (1999) (0)
Risk Factors and Coagulation Disorders – LMWH Pharmacokinetics and Pharmacodynamics (1998) (0)
Haemorrhage and Thrombosis for the MRCOG and Beyond: Venous thromboembolism in obstetrics and gynaecology (2005) (0)
Confidential enquiry into maternal mortality. (1999) (0)
Effects of Algorithm for Diagnosis of Active Labor : Cluster Randomized Trial (2009) (0)
Lipoprotein profile, Low Density Lipoprotein (LDL) subtraction distribution, and hepatic lipase activity in menopausal women with supraphysiological levels of oestrogen (SEI) (1998) (0)
Forthcoming articles in the august issue (2006) (0)
Antiphospholipid syndrome, heritable thrombophilia and early pregnancy loss B Brenner, A Aharon, and G Sarig (2008) (0)
Authors' Reply (1999) (0)
Prevention of venous thromboembolism in pregnancy. (2003) (0)
Urologic Surgery (2013) (0)
More on ‘universal’versus‘selected’ screening for thrombophilia: the hidden costs of false‐positive diagnosis – response to Favaloro and Keeling (2006) (0)
THE INFLUENCE OF FACTOR V LEIDEN AND ABO(H) BLOOD GROUPS ON HAEMATOLOGY PARAMETERS IN EARLY PREGNANCY (2007) (0)
THROMBO–EMBOLIC DISEASE IN OBSTETRICS AND GYNÆCOLOGY (1969) (0)
THE CYTOKINE INTERLEUKIN-6 INCREASES EXPRESSION OF THE CELL ADHESION ON ENDOTHELIAL CELLS IN VITRO: A ROLE IN PREECLAMPSIA? MOLECULES E-SELECTIN AND VCAM-1 (1997) (0)
No headaches Reply (2002) (0)
primary immune thrombocytopenia International consensus report on the investigation and management of (2010) (0)
How to conceive: evidence-based fertility investigation (2008) (0)
AUTHORS' REPLY (1995) (0)
Thrombophilia and maternal mortality: risk factors and preventive approaches (2007) (0)
Reproductive Issues in Women with Bleeding and Thrombotic Disorders (2016) (0)
Venous Thromboembolism Treatment with Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review. (2004) (0)
Preterm Labour: Preface (2005) (0)
P15 A normal range for activated protein C resistance in the third trimester of pregnancy (1997) (0)
Comprar Maternal Medicine | Ian A. Greer | | Churchill Livingstone (2007) (0)
Thrombosis and embolism in pregnancy (2020) (0)
Clinical Outcomes with the LMWH, Tinzaparin (Innohep®) in Pregnancy. An International Retrospective Audit.. (2009) (0)

This paper list is powered by the following services:

Other Resources About Ian Greer

en.wikipedia.org

What Schools Are Affiliated With Ian Greer ?

Ian Greer is affiliated with the following schools:

Ian Greer 's Academic­Influence.com Rankings